Evidence map›Paper›PMID 41299812›Full record

ArticleEmerging microbes & infections2025

Epidemiology, genetic dynamics, and transmission of the

Boqian Wang, Zhong Li, Mingliang Chen, Yuxin Wang, Buaijier Aimaiti, Jingjing Fu, Kexin Li, Zhixi Peng, Rui Zhang, Tianyi Wang and 5 more

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Boqian WangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, People's Republic of China.
Zhong LiDepartment of Stomatology, Hainan Hospital of Chinese PLA General Hospital, Sanya, People's Republic of China.
Mingliang ChenInstitute of Toxicology, School of Military Preventive Medicine, Army Medical University, Chongqing, People's Republic of China.
Yuxin WangChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Buaijier AimaitiChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Jingjing FuLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, People's Republic of China.
Kexin LiChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Zhixi PengChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Rui ZhangChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Tianyi WangChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Honghao WangChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Bin GuDepartment of Stomatology, Hainan Hospital of Chinese PLA General Hospital, Sanya, People's Republic of China.
Hongbin SongChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Hongguang RenLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, People's Republic of China.
Xiaofeng HuChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colistin is a broad-spectrum antibiotic that kills bacteria through the disruption of the cell membrane, making it effective against various bacterial infections. Since the first global report of

Indexed as

Drug Resistance, BacterialEscherichia coli ProteinsAnimalsAnti-Bacterial AgentsChinaColistinGene Transfer, HorizontalHumansMicrobial Sensitivity TestsPlasmidsPoultryAnti-Bacterial AgentsColistinEscherichia coli ProteinsMCR-1 protein, E coliadaptive evolutionaryblaNDMColistinEnterobacteralesIncHI2(A)mcr-1

Identifiers

PMID41299812
PMCPMC12915395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.